Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 2 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
11 70.0 months Malignant peritoneal mesothelioma 4 Chemotherapy
Immunotherapy
Radiation
Surgery
Columbia University New York United States 2/2008
Treatment Details: Patients: This phase 2 study involved 27 malignant peritoneal mesothelioma patients with an average age of 53 years (range of 31-75); 20 were male. Treatment: Patients were treated with
 
12 69.8 months Waldenstrom macroglobulinemia, marginal zone lymphoma,lymphoplasmacytic lymphoma 5 Chemotherapy
UPMC Université Paris France 1/2013
Treatment Details: Patients: This study involved 207 patients with untreated Waldenstrom macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma. The median patient age was 67.8 years and 67
 
13 67.0 months Fallopian tube or primary peritoneal cancer 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 6/2012
Treatment Details: Patients: This study involved 102 female ovarian, fallopian tube, and primary peritoneal cancer patients. The median patient age was 57 years. Treatment: Patients were treated with the
 
14 65.3 months Stage IIB, IIC, and III melanoma 5 Immunotherapy
University General Hospital Attikon Greece 2/2009
Treatment Details: Patients: This phase 3 study involved 353 patients with stage IIB, IIC or III melanoma. These patients had all been treated with surgery (resection). They ranged in age from 19 to 84 year
 
15 65.0 months Advanced Epithelial Ovarian Cancer 4 Chemotherapy
Ospedale San Gerardo Italy 2/2008
Treatment Details: Patients: This phase II study involved two hundred and eight women with advanced epithelial ovarian cancer. The median age was 52, ranging from 24-73 years old. Treatment: Patients wer
 
16 63.7 months Resectable metastatic colorectal carcinoma to the liver 5 Chemotherapy
Surgery
Queens Hospital Center United States 3/2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in this trial
 
17 63.7 months Resectable metastases of colorectal carcinoma to the liver 5 Chemotherapy
Surgery
Queens Hospital Center United States 3/2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in this trial
 
18 62.8 months Advanced ovarian cancer 5 Chemotherapy
Immunotherapy
Städtisches Klinikum Germany 9/2007
Treatment Details: Patients: This phase III study involved one hundred forty-nine women with previously untreated ovarian cancer. All were between the ages of 18 and 65. Treatment: The women received ei
 
19 61.1 months Ovarian cancer 5 Chemotherapy
Istituto Nazionale Tumori Italy 9/2011
Treatment Details: Patients: This phase II study involved patients with stage IC to IV ovarian cancer not previously treated with chemotherapy who were separated into two different treatment groups. Groups A
 
20 60.8 months Low-grade NHL 4 Chemotherapy
Immunotherapy
Fox Chase Cancer Center United States 12/2004
Treatment Details: Patients: This phase II study involved 31 patients with low-grade non-Hodgkin's lymphoma. The median patient age was 62 years and 15 were male. Treatment: Patients were treated with th
 
Page 2 of 187  | Previous Page  | Next Page